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Abstract 
Objective: To examine the laboratory indices in a population aged 65 years or more and compare them with the 
reference values used for young adults. Study design: Distribution patterns of frequently used biochemical and 
hematological indices were examined in a sample (N= 600) of non-institutionalized adults aged over 65.  
Outcome measures: The obtained values were compared with the reference intervals for young adults. 
Results: On some of the indices analyzed, large proportions of the participants had values above the upper limit of 
the reference interval: glucose, 25.0%; urea, 26.6%; creatinine, 27.2% of males; total cholesterol, 54.6%; and low-
density lipoprotein cholesterol, 35.8%. Of the participants who met the World Health Organization’s diagnostic 
criteria for diabetes, 31.8% said they had not been previously diagnosed. Similarly, 74.9% of subjects with total 
cholesterol values above the reference value indicated in the European guidelines on cardiovascular disease said they 
had not been diagnosed with dyslipidemia, as did 75.5% of those with low-density lipoprotein cholesterol values 
above the European reference value. The proportion of participants who were not aware that they might be suffering 
from those disorders was significantly higher among those who reported not having visited their doctor within the last 
6 months. 
Conclusion: Further studies should examine whether the use of adapted, more appropriate reference 
values for elderly populations will help physicians to make early and correct diagnoses and to decide 
when medical intervention is required. 
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1. Introduction 
Laboratory tests are used to detect pathology and confirm diagnoses. To interpret the results of these 
tests, it is necessary to compare them with reference values drawn from a healthy population. 
Unfortunately, the reference population often largely comprises young adults, and this may make the 
reference values inappropriate for an elderly patient. For example, significant agerelated changes have 
been observed in hematological profile [1]. Since the use of inappropriate reference values may impede 
the detection of pathologies in older adults, it would be useful to establish age-specific reference values. 
Few papers have included reference values for adults aged over 65 and some even of these studies 
have included younger subjects [1,2]. A further problem is that where age-appropriate reference intervals 
have indeed been based wholly on samples of healthy older subjects [2–6], the criteria used to determine 
their ‘healthy’ status have varied across studies. 
Most research done with elderly adults not suffering severe disorders has shown that their biochemical 
parameters are in fact within the conventional reference values for young adults [3,4]. Nevertheless, some 
biochemical and hematological indices have shown wider normal (healthy) reference intervals for older 
adults than for young adults [7]. 
A likely reason for the lack of reference values specific to an elderly population is that older adults 
have a relatively high prevalence of chronic pathologies such as diabetes, dyslipidemia, dementia, renal 
disease and anemia [8–11], as well as high comorbidity [12], which makes it difficult to find an 
appropriate healthy reference sample. Furthermore, a large proportion of older subjects regularly take 
medication [13] and many of them are dependent in activities of daily living (ADL) and instrumental 
activities of daily living (IADL) [14]. Again, the use of a strict health criterion is likely to result in a small 
and unrepresentative sample of the elderly population [5]. 
In this study we determined biochemical and hematological indices for a representative sample of 
adults aged over 65 years and compared them with the reference values derived from a younger general 
adult population.  
2. Methods 
2.1. Subjects 
A cross-sectional descriptive study was carried out on a representative sample of 600 people (257 
men, 343 women) aged 65 years or more (75.1±7.5, range 65–101), randomly selected from the Narón 
municipal register (A Coruña, Spain). The level of confidence was 95%, accuracy±4%, and estimation for 
data losses 10%. 
Participants were individually assessed in a health center. Before data collection, all participants were 
informed about the study and signed the corresponding informed consent form. The study protocol was 
approved by the Ethics Committee at the University of A Coruña and conformed to the principles 
embodied in the Declaration of Helsinki. 
2.2. Diabetes and dyslipidemia 
Medical histories were given by the patients or their relatives and their medical records were 
consulted. The Older Americans Resources and Services (OARS) standardized questionnaire [15] was 
used to elicit information regarding pathologies and any visits to the doctor within the last 6 months. 
Locally derived and used reference intervals were used for evaluation of all the indices (see below). In 
addition, the World Health Organization (WHO) reference values for diabetes were consulted [16], as 
were values cited in the ‘European guidelines on cardiovascular disease’ [17] for high total cholesterol 
and high low-density lipoprotein cholesterol (dyslipidemia). 
2.3. Blood collection 
Distribution patterns of the biochemical and hematological indices commonly analyzed in clinical 
chemistry were explored. The specific biochemical indices analyzed were glucose, urea, creatinine, uric 
acid, aspartate aminotransferase (AST), alanine aminotransferase (ALAT), gamma glutamyl 
transpeptidase (GGT), total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-
cholesterol), low-density lipoprotein cholesterol (LDL-cholesterol), phosphorus, calcium and thyroid-
stimulating hormone (TSH). The specific hematological indices analyzed were leucocyte count, 
erythrocyte count, hemoglobin (Hb), hematocrit (HCT), mean corpuscular volume (MCV), mean 
corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), platelet count 
and erythrocyte sedimentation rate (ESR). 
Blood samples were collected at a primary health care center. For all participants, samples were drawn 
in the morning, after an overnight fast. Samples for the biochemical indices were collected into SST-gel 
tubes and those for the hematological indices into EDTA tubes. For determination of the biochemical and 
hematological indices, analyses were done using 4ml Vacutainer tubes (Becton Dickinson); Seditainer 
tubes were used for the ESR determination. Biochemistry tubes were centrifugated at room temperature at 
3000 rpm. The biochemical indices were determined using an Advia analyzer (Bayer Diagnostics) and 
the hematological indices were determined using a Beckman-Coulter analyzer. All measurements were 
reported in SI units. 
All analyses were performed in the laboratories of the Complejo Hospitalario Universitario (CHUAC) 
in A Coruña city on the day of sample collection. 
2.4. Statistical analysis 
A descriptive analysis of the biochemical and hematological indices was carried out; the mean 
(standard deviation) and median values, maximum and minimum values and the 2.5th and 97.5th 
percentiles were calculated for each parameter. These values were compared with the CHUAC reference 
intervals used by the Galician Health Service (SERGAS). Gender-specific intervals were used where 
appropriate. The number and percentage of sample results that were higher or lower than the CHUAC 
reference intervals were identified. Results that were more than 5% above the upper end of the reference 
interval or 5% below the lower value were considered to be significantly different from a population 
perspective. 
For any indices on which more than 25% of participants returned values above those of the reference 
intervals, further exploration was done. This applied to glucose and cholesterol. The number and 
percentage of subjects with had glucose levels above the reference interval who reported having been 
diagnosed with diabetes were noted, as were the number and percentage of subjects with levels of 
cholesterol above the reference value who reported having been diagnosed with dyslipidemia. Finally, a 
chi-square test was performed to determine whether awareness of a diagnosis of dyslipidemia and 
diabetes was related to having visited a doctor within the last 6 months. 
Statistical analysis was performed using SPPS software version 16.0.2 [18]. 
3. Results 
Table 1 summarizes the results for each biochemical and hematological index for the whole sample. 
Table 2 shows the reference intervals for the biochemical and hematological indices, and the number 
and frequency of values from the study sample that fell below and above those intervals. 
3.1. Biochemical indices (see Tables 1 and 2) 
The mean glucose concentration in the study sample was 5.5±1.4 mmol/l, and 25.0% of the subjects 
had glucose values above the CHUAC reference interval. The mean urea concentration was 7.6±2.5 
mmol/l, and 26.6% of participants had values above the reference interval. Among women, the mean 
creatinine level was 89±18 µmol/l and among men it was 106±27µmol/l; 13.0% of the women and 27.2% 
of the men had values above the reference interval. The mean concentration of uric acid was 
300±72µmol/l in women and 377±90 µmol/l in men; 24.5% of women and 22.9% of men had values 
above the reference interval. 
If we refer to transaminases, the mean AST value was 0.37±0.27 µkat/l, and 97% of participants were 
within the reference range. The mean ALAT value was 0.43±0.54 µkat/l in women and 0.45±0.25 µkat/l 
in men; 6.3% of women and 8.1% of men had ALAT levels above the reference interval. The mean GGT 
value was 22±29 U/l and it was found that 10.1% of all participants had GGT levels above the reference 
interval. 
As regards cholesterol, mean values were 5.8±1.1 mmol/l for total cholesterol, 1.5±0.4 mmol/l for 
HDL-cholesterol and 3.6±0.9 mmol/l for LDL-cholesterol; 54.6% of the sample had levels of total 
cholesterol above the reference value, and 35.8% had levels of LDL-cholesterol above the reference 
value. 
The mean concentration of triglycerides was 1.8±1.1 µmol/l, and 12.9% of participants had levels above 
the reference interval. The mean concentration of phosphorus was 1.0±0.2 mmol/l, and 8.6% of the 
subjects had levels below the reference interval. The meancalcium concentrationwas2.3±0.1 mmol/l, and 
99.0% of participants were within the reference range. The TSH mean value was 2.34±7.19 mIU/l; 3.8% 
of participants had TSH levels below the reference interval and 2.9% had levels above. 
3.2. Hematological indices (see Tables 1 and 2) 
The mean sample leucocyte count was 5.0±2.5×109/l, and 95.1% of participants fell within the 
reference interval. The mean erythrocyte count was 4.6±0.4×1012/l in women and 4.8±0.5×1012/l in 
men; 22.0% of women had an erythrocyte above the reference range and 6.2% below, and 3.5% of men 
had a count above the reference range and 15.5% below. The mean Hb concentrationwas8.4± 0.6 mmol/l 
inwomenand 9.2±0.8 mmol/l inmen; 97.2% of women and 96.6% of men had values within the reference 
interval. The mean HCT value was 0.40±0.03 for women and 0.44±0.04 for men; 4.8% of women and 
12.6% of men had HCT values below the reference range, and 3.9% of women and 3.5% of men had 
values above. 
The mean MCV within the whole sample was 89±6 fl and 95.1% of participants had values within the 
reference interval. The mean MCH value was 30.1±2.1 pg/cell and 5.3% of the sample returned values 
that were above the reference interval. The mean MCHC was 336±9 g/l, and 99.5% of participants 
returned values within the reference interval. The mean platelet count was 236±69×109/l, and 95.8% of 
participants had counts within the reference interval. The mean ESR was 17±16 mm/h, and 24.8% of 
participants had counts that were above the reference interval. 
3.3. Glucose and diabetes 
As reported in Table 2, 145 participants had glucose levels above the CHUAC reference range. Table 
3 divides this subsample according to whether or not they had had a diagnosis of diabetes; it also 
similarly reports the diagnosis of diabetes among the 88 participants (15.2% of the 580 who had a glucose   
Table 1 
Descriptive statistics of laboratory values.  
 n Mean (SD) Median 2.5th and 97.5th percentiles Range 
Biochemistry      
Glucose (mmol/l) 580 5.5 (1.4) 5.2 4.0–8.5 2.1–19.3 
Urea (mmol/l)  579 7.6 (2.5) 7.1 4.2–14.8 2.9–26.9 
Creatinine (µmol/l)      
Female  330 89 (18) 89 62–133 62–248 
Male 243 106 (27) 98 80–160 71–381 
Uric acid (µmol/l)      
Female 326 300 (72) 294 174–474 0–714 
Male 245 377 (90) 372 222–576 174–810 
AST (µkat/l)  574 0.37 (0.27) 0.35 0.22–0.66 0.17–4.33 
ALAT (µkat/l)      
Female 333 0.43 (0.54) 0.36 0.20–0.91 0.13–9.00 
Male 247 0.45 (0.25) 0.40  0.22–1.23 0.17–2.35 
GGT (U/l) 566 22 (29) 15 6–86 4–422 
Total cholesterol (mmol/l)  581 5.8 (1.1) 5.8 3.5–8.0 3.0–11.1 
Triglycerides (µmol/l)  580 1.8 (1.1) 1.6 0.7–4.0 0.5–19.1 
HDL-cholesterol (mmol/l) 570 1.5 (0.4) 1.5 0.91–2.33 0.6–3.1 
LDL-cholesterol (mmol/l)  567 3.6 (0.9) 3.5 1.9–5.5 0.9–6.6 
Phosphorus (mmol/l)  547 1.0 (0.2) 1.0 0.7–1.3 0.6–1.8 
Calcium (mmol/l)  548 2.3 (0.1) 2.3 2.1–2.5 0.2–2.7 
TSH (mIU/l)  558 2.34 (7.19) 1.45 0.26–5.84 0.00–148.00 
Hematology      
Leucocyte count (×109/l) 549 5.0 (2.5) 6.3 3.9–11.4 2.2–39.9 
Erythrocyte count (×1012/l)      
Female  331 4.6 (0.4) 4.6 3.7–5.4 3.0–5.9 
Male 247 4.8 (0.5) 4.9 3.9–5.7 2.0–6.4 
Hb (mmol/l)      
Female 331 8.4 (0.6) 8.3 7.2–9.6 6.3–9.9 
Male 247 9.2 (0.8) 9.3 7.3–10.8 5.2–12.2 
HCT      
Female 331 0.40 (0.03) 0.41 0.32–0.46 0.24–0.48 
Male 247 0.44 (0.04) 0.44 0.36–0.51 0.25–0.57 
MCV (fl)  578 89 (6) 89 79–100 58–128 
MCH (pg/cell)  578 30.1 (2.1) 30.1 25.6–33.8 19.3–42.6 
MCHC (g/l)  578 336 (9) 336 316–355 302–388 
Platelet (×109/l)  578 236 (69) 230 123–401 44–630 
ESR (mm/h)  545 17 (16) 12 2–58 1–120 
      
SD = standard deviation; ALAT = alanine aminotransferase; AST = aspartate aminotransferase; ESR = erythrocyte sedimentation 
rate; GGT=gamma glutamyl transpeptidase;HCT = hematocrit; Hb= hemoglobin; HDL-cholesterol = high-density lipoprotein 
cholesterol; LDL-cholesterol = low-density lipoprotein cholesterol; MCH=mean corpuscular hemoglobin; MCHC=mean 
corpuscular hemoglobin concentration; MCV=mean corpuscular volume; TSH = thyroid-stimulating hormone. 
determination) who had glucose values above the WHO reference interval. As can be seen, 51.7% of 
people with glucose values above the CHUAC reference interval did not report diabetes. The current 
WHO diagnostic criteria for diabetes stipulate a concentration of fasting plasma glucose above 7.0 mmol/l 
(126 mg/dl) and 88 participants (15.2%) in our sample fulfilled this criterion; of these, 31.8% had not 
received a diagnosis of diabetes. Furthermore, the percentage of participants with fasting plasma glucose 
above 7 mmol/l who did not report a diabetes diagnosis was significantly higher (p = 0.001) among those 
who had not visited their doctor within the previous 6 months (63.2%) than among those who had visited 
their doctor (23.2%). 
3.4. Cholesterol and dyslipidemia 
As reported in Table 2, 317 participants had total cholesterol levels above the CHUAC reference value 
and 203 had LDL-cholesterol above the CHUAC reference value. Table 4 divides these subsamples 
according to whether or not they had had a diagnosis of dyslipidemia; it also similarly reports the 
diagnosis of dyslipidemiaamong the participants who had cholesterol values (total and LDL) above the 
reference values indicated in the European guidelines [17]. As shown, 72.6% of subjects with total 
cholesterol and 72.4% of those with LDL-cholesterol above the CHUAC reference value did not report 
having received a diagnosis of dyslipidemia.  
Table 2 
Number and percentage of values above and below the reference intervals. 
 Reference intervals  Frequencies 
  Low  Normal  High 
  n %  n %  n % 
          
Biochemistry          
Glucose (mmol/l)  3.9–5.6 7 1.2  428 73.8  145 25.0 
Urea (mmol/l) 3.4–8.3 2 0.3  423 73.1  154 26.6 
Creatinine (µmol/l)          
Female  43–98    287 87.0  43 13.0 
Male  53–106    177 72.8  66 27.2 
Uric acid (µmol/l)          
Female 144–342 2 0.6  244 74.9  80 24.5 
Male 204–420 2 0.8  187 76.3  56 22.9 
AST (µkat/l) 0.08–0.66    557 97.0  17 3.0 
ALAT (µkat/l)          
Female 0.10–0.66    312 93.7  21 6.3 
Male 0.10–0.75    227 91.9  20 8.1 
GGT (U/l) 5–36 2 0.4  507 89.5  57 10.1 
Total cholesterol (mmol/l)  ≤5.7    264 4 45.  317 54.6 
Triglycerides (µmol/l)  0.3–2.3    505 87.1  75 12.9 
HDL-cholesterol (mmol/l)  0.9–2.3 11 1.9  538 94.4  21 3.7 
LDL-cholesterol (mmol/l)  ≤3.9    364 64.2  203 35.8 
Phosphorus (mmol/l)  0.8–1.4 47 8.6  494 90.3  6 1.1 
Calcium (mmol/l)  2.0–2.5 3 0.5  542 99.0  3 0.5 
TSH (mIU/l)  0.35–5.50 21 3.8  521 93.3  16 2.9 
Hematology          
Leucocyte count (×109/l)  4.0–11.5 15 2.6  543 95.1  13 2.3 
Erythrocyte count (×1012/l)          
Female 4.0–4.8 19 6.2  218 71.8  67 22.0 
Male 4.5–5.5 35 15.5  183 81.0  8 3.5 
Hb (mmol/l)          
Female 7.4–9.9 9 2.8  311 97.2    
Male  8.1–11.2 7 3.0  225 96.6  1 0.4 
HCT          
Female  0.41–0.50 15 4.8  283 91.3  12 3.9 
Male  0.36–0.45 29 12.6  194 83.9  8 3.5 
MCV (fl)  80–99 12 2.1  544 95.1  16 2.8 
MCH (pg/cell)  26.0–32.0 8 1.5  493 93.2  28 5.3 
MCHC (g/l)  310–360    569 99.5  3 0.5 
Platelet (×109/l)  130–450 18 3.1  554 95.8  6 1.0 
ESR (mm/h)  1–20    410 75.2  135 24.8 
          
Values in which more than 25% of participants showed results above those of the reference intervals are presented in bold. 
According to the “European guidelines on cardiovascular disease prevention in clinical practice”, total 
plasma cholesterol should be below 5 mmol/l and LDL-cholesterol should be below 3 mmol/l, but 79.5% 
of participants in the present study had cholesterol levels above 5 mmol/l. Of these, 74.9% did not report 
having received a diagnosis of dyslipidemia. As regards LDL-cholesterol, 75.5% of the 567 participants 
who had a determination had levels above 3 mmol/l. Of these 428 participants, a further 75.5% did not 
report having received a diagnosis of dyslipidemia. 
In those subjects with a level of total cholesterol above 5 mmol/l, the percentage of those who did not 
report having received a diagnosis of dyslipidemia was significantly higher (p = 0.001) among those who 
had not visited their doctor within the last 6 months (88.8%) than among those who did report a visit 
(71.6%). Also, among those subjects with levels of LDL-cholesterol above 3 mmol/l, the percentage of 
people who did not report having received a diagnosis of dyslipidemia was significantly higher (p = 
0.006) among those who had not visited their doctor within the last 6 months (87.5% vs. 12.5%).  
Table 3 
Number and percentage of subjects with glucose levels above the CHUAC and WHO reference intervals reporting a previous 
diagnosis or no diagnosis of diabetes. 
 No diagnosis  Diagnosis 
 n %  n % 
      
CHUAC (≥5.6 mmol/l) 75 51.7  70 48.3 
WHO (≥7.0 mmol/l) 28 31.8  60 68.2 
      
CHUAC= Complejo Hospitalario Universitario A Coruña; WHO=World Health Organization. 
Table 4 
Number and percentage of subjects with cholesterol levels above the CHUAC and European reference intervals reporting a previous 
diagnosis or no diagnosis of dyslipidemia. 
 No diagnosis  Diagnosis 
 n %  n % 
      
CHUAC      
Total cholesterol (≤5.7 mmol/l) 230 72.6  87 27.4 
LDL-cholesterol (≤3.9 mmol/l) 147 72.4  56 27.6 
European      
Total cholesterol (>5 mmol/l) 346 74.9  116 25.1 
LDL-cholesterol (>3 mmol/l) 323 75.5  105 24.5 
      
CHUAC= Complejo Hospitalario Universitario A Coruña. European reference interval = “European guidelines on cardiovascular 
disease prevention on clinical practice” [17]. 
4. Discussion 
On most of the biochemical indices, a significant percentage of the participants had values outside the 
reference range. Only in the case of the AST and calcium did more than 95% of participants have values 
within the reference intervals. The hematological indices on which more than 95% of participants were 
within the reference intervals were leucocyte count, Hb, MCV, MCHC and platelet count. These results 
are consistent with those reached in a previous study [19]. Thus, few reference intervals for hematological 
and biochemical indices can be applied directly to community-living elderly subjects without finding an 
excess of out-of-range values. 
In our study, 25% or more of the participants had levels of glucose, urea, creatinine (in males), total 
cholesterol and LDL cholesterol above the local reference intervals. Some studies have found that plasma 
urea levels increase with age, but no relation has been observed between age and plasma creatinine levels 
[20,21]. The high levels of plasma creatinine found in males could be an indication of kidney failure. 
However, apart from age and sex, the plasma creatinine is also affected by other variables, including 
weight and ethnicity. Consequently, plasma creatinine levels should not be used alone to assess the 
kidney function; the Cockroff and Gault formula (CGCC) [22] or the MDRD2 equation [23], which take 
into account these variables, are more accurate methods of assessment. 
The high levels of glucose and cholesterol are particularly noteworthy, as they will have important 
consequences on health and quality of life, especially for older adults. Diabetes among older adults is a 
risk factor of cardiovascular events [24] and increases the risk of mortality [25], although the precise role 
of cholesterol in cardiovascular mortality among the elderly is not as clear as it is for more middle-aged 
populations. Nevertheless, some studies suggest that total cholesterol is an important risk factor for 
mortality due to coronary disease in the elderly [26,27]. 
We found that a large proportion (31.8%) of those subjects who fulfilled the WHO’s criterion for 
diabetes (i.e. a glucose level ≥7.0 mmol/l) did not report having received a diagnosis of diabetes; 
similarly, large proportions (around three-quarters) of the participants with high levels of total cholesterol 
and LDL-cholesterol did not report having received a diagnosis of dyslipidemia (Table 4). This is 
particularly worrying because it indicates these subjects are not aware of their condition and are not in 
receipt of appropriate medical treatment. 
The percentage of people who did not know they fulfilled the diagnostic criteria for these two 
disorders was significantly higher among those who had not visited the doctor within the last 6 months. In 
other studies it has been shown that having two or more visits to the doctor annually is associated with 
awareness of dyslipidemia and diabetes [8]. 
A problem we face when it comes to comparing laboratory values reported in the literature is the use 
of different techniques and reference values. It would be desirable to harmonize the methods of 
measurement and the reference values used by different laboratories, as this would mean that patient 
results would be transferable, which in turn would amplify health benefits and reduce the demand on 
health systems [28]. 
Clinical chemistry reference values should be separately specified for elderly persons and these should 
be re-evaluated regularly to ensure that they remain appropriate [5]. For many of the biochemical and 
hematological indices we investigated, an excess of values was found outside the reference range set for a 
younger adult population. It is important to establish optimal reference values for the elderly which take 
into account the particularities of this group, as this will help the doctors to provide an early and correct 
diagnosis. In this regard, since laboratory tests are frequently used to detect severe and/or chronic 
pathologies, the use of adapted, more appropriate reference values for the elderly would help to establish 
the point at which medical intervention is appropriate for older patients. 
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